# Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome

> **NCT00454688** · PHASE2 · COMPLETED · sponsor: **Tioga Pharmaceuticals** · enrollment: 596 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Asimadoline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00454688
- **Lead sponsor:** Tioga Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 596 (ACTUAL)
- **Last updated:** 2011-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454688, "Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00454688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*